Please use this identifier to cite or link to this item:
http://hdl.handle.net/10397/90713
DC Field | Value | Language |
---|---|---|
dc.contributor | Department of Biomedical Engineering | en_US |
dc.creator | Lee, TMH | en_US |
dc.date.accessioned | 2021-08-27T02:33:48Z | - |
dc.date.available | 2021-08-27T02:33:48Z | - |
dc.identifier.uri | http://hdl.handle.net/10397/90713 | - |
dc.language.iso | en | en_US |
dc.rights | Posted with permission of the author. | en_US |
dc.title | Functionalized gold nanoparticles for point-of-care nucleic acid detection | en_US |
dc.type | Other Conference Contributions | en_US |
dc.identifier.spage | 1 | en_US |
dcterms.abstract | Gold nanoparticles (AuNPs) have been extensively investigated for colorimetric detection of nucleic acid. This is enabled by the unique interparticle distance-dependent optical property of AuNPs. The solution color for monodispersed particles appears red (for widely used 13 nm AuNPs) but turns purple upon aggregation due to a red-shift in the surface plasmon resonance absorption band. Until now, all the reported platforms are not practical for point-of-care testing. To address this, our group developed a new platform by incorporating 11-mercaptoundecanoic acid-modified AuNPs (MUA–AuNPs) into loop-mediated isothermal amplification (LAMP). When added into the LAMP reaction mixture, MUA–AuNPs aggregated as a result of ion-templated chelation between the carboxyl groups and magnesium ion (Mg2+, which plays an indispensable role in LAMP reaction as an enzyme cofactor). The solution color changed from red to purple. In the presence of a specific target DNA sequence, the LAMP reaction occurred and pyrophosphate ion (P2O74−) was generated as a reaction by-product. The chelated Mg2+ was then extracted by P2O74−, leading to the deaggregation/redispersion of the MUA–AuNPs and the solution color turned red. This new platform possesses all the ideal features for point-of-care testing, including simple preparation and operation, low cost, high sensitivity, and worry-free carryover contamination control. | en_US |
dcterms.accessRights | open access | en_US |
dcterms.bibliographicCitation | World Congress on Medical Physics & Biomedical Engineering, 7-12 June 2015, Toronto, Canada, p.1 (Abstract) | en_US |
dcterms.issued | 2015 | - |
dc.relation.conference | World Congress on Medical Physics & Biomedical Engineering | en_US |
dc.description.validate | 202108 bcrc | en_US |
dc.description.oa | Not applicable | en_US |
dc.identifier.FolderNumber | a0842-n04 | - |
dc.identifier.SubFormID | 1731 | - |
dc.description.fundingSource | RGC | en_US |
dc.description.fundingText | 501413 | en_US |
dc.description.oaCategory | Copyright retained by author | en_US |
Appears in Collections: | Conference Paper |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
a0842-n04_1731.pdf | 935.39 kB | Adobe PDF | View/Open |
Page views
150
Last Week
1
1
Last month
Citations as of Apr 14, 2025
Downloads
42
Citations as of Apr 14, 2025

Google ScholarTM
Check
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.